Advanced Practice Providers

Burnout

Concierge Medicine

Concierge Medicine 2.0 by Castle Connolly Private Health Partners

Employment Trends

Learning and Development

Locum Tenens, brought to you by LocumLife®

Maintenance of Certification

Careers

Contract Negotiation

Insurance

Malpractice

Risk Management

Legal

Opinion

Estate Planning

Investing

Retirement Planning

Physician's Money Digest

Industry Trends

Medicare & Medicaid

Pharma Industry

Physician Advocacy

Politics

Policy

Billing and Collections

Payment Models

Practice Valuation

Practice valuation

Reimbursement

Revenue Cycle Management

Practice Finance

Chronic Condition Management

Coding and Documentation

Leadership

Marketing

Patient Relations

Staffing

Vaccines

Practice Management

100 Years of Medical Economics

Exclusive Content 

Special Reports

Cybersecurity

EHRs

Medical Technology

Remote Patient Monitoring

Telehealth

Technology

News

All News

Money

Physicians Financial News

Media

Around the Practice

Between The Lines

Clinical Consult

Expert Interviews

Medical Economics Pulse

Medical World News

Off The Charts Podcasts

Physician Report

PrimaryView

Academy

Conferences

Conference Coverage

Conference Listing

Publications

Medical Economics

Supplements And Featured Publications

CME/CE

Job Board

Subscribe

Directories

Financial Advisor Guide

Medical Economics is the leading health care business media brand for physicians, serving our audience of doctors through our print magazine, in-depth features, video interviews, podcasts and more.

About

Advertise

Contact Us

Editorial Staff

Terms and Conditions

Contributor Guidelines

Privacy Policy

Do Not Sell My Personal Information

Facebook

LinkedIn

Business Focus

Career Planning

Electronic Health Records

Personal Finance

Value-based Care

Locum Tenens

Clinical  Focus

Allergy and Immunology

Cardiology

Dermatology

Endocrinology

Gastroenterology

Infectious Disease

Neurology

Pain Management

Pediatrics

Psychiatry

Pulmonology

Rheumatology

Women's Health

Spotlight

The benefits of a physician MBA program

Physician Bootcamp

1rem

Authors

Cabozantinib (XL184), a novel tyrosine kinase inhibitor, caused the deaths of 6 patients in a phase II clinical trial, according to data presented at ASCO's annual meeting. The fatalities had not been reported with the cabozantinib data at the May 18 pre-ASCO press briefing. Shares of the drug's manufacturer, Exelixis, fell 20% as investors reacted to the news.

Updated Cabozantinib Data Includes 6 Patient Deaths

This is your chance to tell us about staffing and salaries in your office as the 

Your answers will inform Physicians Practice stories going forward.

The 2024 Physicians Practice Staff Salary survey is now available, offering an opportunity to provide insights on staffing and salaries within medical offices. Participation in the survey will contribute valuable data that will shape future stories and analyses by Physicians Practice. This initiative aims to gather comprehensive information on current compensation trends and staffing dynamics, which are crucial for understanding the evolving landscape of medical practice management. The collected data will be instrumental in informing industry professionals about prevailing salary benchmarks and staffing practices.

Don't miss your chance to see how your practice measures up.

Topics

Take the Staff Salary Survey now!

GLP-1 RA antiobesity medications: Lifestyle changes are needed too

. He has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine. His next book, “Patient Centered Weight Management: The Six Factor Professional Program & Toolkit,” written for medical and health care professionals, is due out in 2025, with his wife and co-author, Nancy Kushner, MSN, RN. It is the follow-up to his volume, “Six Factors to Fit: Weight Loss That Works for You!”

Lifestyle modifications are crucial when patients start using GLP-1 RA antiobesity drugs, according to Dr. Robert Kushner, a seasoned researcher and clinician in obesity and nutrition. Dr. Kushner emphasizes the integration of lifestyle changes with pharmacotherapy for effective weight management. His upcoming book, "Patient Centered Weight Management: The Six Factor Professional Program & Toolkit," aims to provide healthcare professionals with comprehensive strategies for patient-centered weight management. This work builds on his previous publication, "Six Factors to Fit: Weight Loss That Works for You!"

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Weight Management

GLP-1 RA antiobesity medications: Lifestyle changes needed too

GLP-1 RA antiobesity medications: Talking about cost

 are effective – and expensive. How should physicians talk about this with 

, discusses the financial factors that affect patient treatment for obesity. He has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.

The introduction of GLP-1 receptor agonists (RAs) has shown significant efficacy in obesity treatment, but their high cost presents a challenge for patient access. Physicians must navigate these financial barriers when discussing treatment options with patients. Dr. Robert Kushner, an expert in obesity and nutrition, emphasizes the importance of transparent communication regarding the financial implications of these medications. His extensive experience in both research and clinical practice at Northwestern University underscores the need for balancing effective treatment with patient affordability and accessibility.

All of Trump's health care picks

President-elect Donald Trump has officially made several announcements regarding his nominations for major health care openings in his new administration. His picks include Robert F. Kennedy Jr. as secretary of the U.S. Department of Health and Human Services (HHS), Jim O'Neill as deputy secretary of HHS, Mehmet Oz, MD, MBA, as the head of the Centers for Medicare & Medicaid Services (CMS), Dave Weldon, MD, as director of the U.S. Centers for Disease Control and Prevention (CDC), Marty Makary, MD, MPH, FACS, commissioner of the U.S. Food and Drug Administration (FDA), Janette Nesheiwat, MD, as surgeon general and Jay Bhattacharya, MD, PhD, to lead the National Institutes of Health (NIH).

Donald Trump has announced his nominations for key healthcare positions in his administration. Robert F. Kennedy Jr. is nominated for Secretary of Health and Human Services, while Mehmet Oz is chosen to lead the Centers for Medicare & Medicaid Services. Dave Weldon is selected as the Director of the Centers for Disease Control and Prevention, and Marty Makary is nominated as the Commissioner of the Food and Drug Administration. Janette Nesheiwat is appointed as the Surgeon General. These selections reflect a diverse range of expertise and backgrounds in healthcare leadership.

President-elect Donald Trump's nominations for major positions of leadership in health care in his new administration—including HHS, CMS, CDC, FDA, NIH and surgeon general.  

The leaders of health care in the new Trump administration

This eBook will walk readers through what AI is and highlight how AI is transforming healthcare, especially in patient scheduling. AI solutions like Veradigm's Predictive Scheduler can optimize schedules by using machine learning to predict patient needs, reducing wait times and easing staff burdens. 

Traditional scheduling methods can be inefficient, leading to prolonged wait times and adding stress to already limited staff. By automating scheduling and prioritizing patients, AI addresses staffing shortages, lowers no-shows, and boosts productivity. 

The eBook will also present a case study on how an AI-optimized scheduling system uncovered potential revenue by up to $1.8 million.

Fill out the form below for more information. 

AI is revolutionizing healthcare, particularly in patient scheduling, by employing machine learning to predict patient needs and optimize schedules. Solutions like Veradigm's Predictive Scheduler help reduce wait times and alleviate staff burdens. Traditional scheduling methods often lead to inefficiencies, prolonged wait times, and increased stress on limited staff. AI-driven automation addresses these issues by prioritizing patients, reducing no-shows, and enhancing productivity. A case study demonstrates how an AI-optimized scheduling system can potentially uncover significant revenue, exemplified by an increase of up to $1.8 million.

This eBook will walk readers through what AI is and highlight how AI is transforming healthcare, especially in patient scheduling. Integrating AI, like Veradigm’s Predictive Scheduler, can optimize schedules by using machine learning to predict patient needs, reducing wait times and easing staff burdens. 

Traditional scheduling methods can be inefficient, leading to prolonged wait times and adding stress to already limited staff. By automating scheduling and prioritizing patients, AI addresses staffing shortages, lowers no-shows, and boosts productivity. The eBook will also present a case study on how an AI-optimized scheduling system uncovered potential revenue by up to $1.8 million.

How Artificial Intelligence is Transforming Patient Scheduling

Jay W Lee, MD, MPH, FAAFP, discusses the CDC's latest vaccine recommendations

Dr Jay W Lee Interview on vaccine recommendations

The Centers for Disease Control and Prevention (CDC) recently 

, a member of the American Academy of Family Physicians (AAFP) board of directors and the medical director at Integrated Health Partners of Southern California, discussed the most recent changes to these recommendations, including additional doses of the COVID-19 vaccine for certain patients.

The CDC has updated its recommendations for COVID-19 and pneumococcal vaccinations. These changes include additional COVID-19 vaccine doses for specific patient groups. Jay W. Lee, MD, MPH, FAAFP, a board member of the AAFP and medical director at Integrated Health Partners of Southern California, elaborated on these updates in a recent interview. The adjustments aim to enhance protection for vulnerable populations and align with evolving epidemiological data. Healthcare providers are encouraged to stay informed about these updates to ensure optimal patient care and vaccination strategies.

Jay W. Lee, MD, MPH, FAAFP, discusses the CDC's latest guidelines regarding the COVID-19 vaccine and expanded recommendations for pneumococcal vaccines.

The CDC's latest recommendations for COVID-19 and pneumococcal vaccines

Jason M. Broderick

Articles

Latest Updated Articles